RankingsPricing
  1. US-listed companies
  2. ACADIA PHARMACEUTICALS INC
  3. Financials
  4. Net income margin (%)

ACADIA PHARMACEUTICALS INCACAD

Market cap
$4B
P/E ratio
SummaryFinancials
Period EndNet income margin (%) YoY (%)
Dec 31, 202423.6-380.24%
Dec 31, 2023-8.4-79.80%
Dec 31, 2022-41.8+20.43%
Dec 31, 2021-34.7-45.60%
Dec 31, 2020-63.7-8.13%
Dec 31, 2019-69.4-36.67%
Dec 31, 2018-109.6-52.72%
Dec 31, 2017-231.7-85.20%
Dec 31, 2016-1,565.9-99.42%
Dec 31, 2015-269,578.7+249.82%
Dec 31, 2014-77,062.5+2225.20%
Dec 31, 2013-3,314.2+680.04%
Dec 31, 2012-424.9-61.42%
Dec 31, 2011-1,101.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)